214 related articles for article (PubMed ID: 22022391)
61. Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus.
Jiang D; Guo H; Xu C; Chang J; Gu B; Wang L; Block TM; Guo JT
J Virol; 2008 Feb; 82(4):1665-78. PubMed ID: 18077728
[TBL] [Abstract][Full Text] [Related]
62. Identification of a ribavirin-resistant NS5B mutation of hepatitis C virus during ribavirin monotherapy.
Young KC; Lindsay KL; Lee KJ; Liu WC; He JW; Milstein SL; Lai MM
Hepatology; 2003 Oct; 38(4):869-78. PubMed ID: 14512874
[TBL] [Abstract][Full Text] [Related]
63. Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation.
Pulit-Penaloza JA; Scherbik SV; Brinton MA
Virology; 2012 Apr; 425(2):71-81. PubMed ID: 22305621
[TBL] [Abstract][Full Text] [Related]
64. Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins.
Nanda SK; Baron MD
J Virol; 2006 Aug; 80(15):7555-68. PubMed ID: 16840335
[TBL] [Abstract][Full Text] [Related]
65. STAT1 N-terminal domain discriminatively controls type I and type II IFN signaling.
Göder A; Ginter T; Heinzel T; Stroh S; Fahrer J; Henke A; Krämer OH
Cytokine; 2021 Aug; 144():155552. PubMed ID: 34000478
[TBL] [Abstract][Full Text] [Related]
66. Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway.
Liu WL; Yang HC; Su WC; Wang CC; Chen HL; Wang HY; Huang WH; Chen DS; Lai MY
PLoS One; 2012; 7(9):e43824. PubMed ID: 22962590
[TBL] [Abstract][Full Text] [Related]
67. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
[TBL] [Abstract][Full Text] [Related]
68. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression.
Liu Y; Zhang Z; Zhao X; Yu R; Zhang X; Wu S; Liu J; Chi X; Song X; Fu L; Yu Y; Hou L; Chen W
Viral Immunol; 2014 Aug; 27(6):267-76. PubMed ID: 24905060
[TBL] [Abstract][Full Text] [Related]
69. PRL-3 induces a positive signaling circuit between glycolysis and activation of STAT1/2.
Vandsemb EN; Rye MB; Steiro IJ; Elsaadi S; Rø TB; Slørdahl TS; Sponaas AM; Børset M; Abdollahi P
FEBS J; 2021 Dec; 288(23):6700-6715. PubMed ID: 34092011
[TBL] [Abstract][Full Text] [Related]
70. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
[TBL] [Abstract][Full Text] [Related]
71. HuR Displaces Polypyrimidine Tract Binding Protein To Facilitate La Binding to the 3' Untranslated Region and Enhances Hepatitis C Virus Replication.
Shwetha S; Kumar A; Mullick R; Vasudevan D; Mukherjee N; Das S
J Virol; 2015 Nov; 89(22):11356-71. PubMed ID: 26339049
[TBL] [Abstract][Full Text] [Related]
72. Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
Gale M; Kwieciszewski B; Dossett M; Nakao H; Katze MG
J Virol; 1999 Aug; 73(8):6506-16. PubMed ID: 10400746
[TBL] [Abstract][Full Text] [Related]
73. Hepatitis C virus replication is inhibited by 22beta-methoxyolean-12-ene-3beta, 24(4beta)-diol (ME3738) through enhancing interferon-beta.
Hiasa Y; Kuzuhara H; Tokumoto Y; Konishi I; Yamashita N; Matsuura B; Michitaka K; Chung RT; Onji M
Hepatology; 2008 Jul; 48(1):59-69. PubMed ID: 18459156
[TBL] [Abstract][Full Text] [Related]
74. Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus Induces STAT2 Degradation To Inhibit Interferon Signaling.
Yang L; He J; Wang R; Zhang X; Lin S; Ma Z; Zhang Y
J Virol; 2019 Nov; 93(22):. PubMed ID: 31462568
[TBL] [Abstract][Full Text] [Related]
75. Structural Basis of the Inhibition of STAT1 Activity by Sendai Virus C Protein.
Oda K; Matoba Y; Irie T; Kawabata R; Fukushi M; Sugiyama M; Sakaguchi T
J Virol; 2015 Nov; 89(22):11487-99. PubMed ID: 26339056
[TBL] [Abstract][Full Text] [Related]
76. Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro.
Kuga C; Enomoto H; Aizawa N; Takashima T; Ikeda N; Ishii A; Sakai Y; Iwata Y; Tanaka H; Saito M; Iijma H; Nishiguchi S
Biochem Biophys Res Commun; 2014 Nov; 454(3):453-8. PubMed ID: 25450683
[TBL] [Abstract][Full Text] [Related]
77. Antiviral potency analysis and functional comparison of consensus interferon, interferon-alpha2a and pegylated interferon-alpha2b against hepatitis C virus infection.
Erickson AK; Seiwert S; Gale M
Antivir Ther; 2008; 13(7):851-62. PubMed ID: 19043919
[TBL] [Abstract][Full Text] [Related]
78. Hepatitis C virus expression suppresses interferon signaling by degrading STAT1.
Lin W; Choe WH; Hiasa Y; Kamegaya Y; Blackard JT; Schmidt EV; Chung RT
Gastroenterology; 2005 Apr; 128(4):1034-41. PubMed ID: 15825084
[TBL] [Abstract][Full Text] [Related]
79. STAT2-dependent induction of RNA adenosine deaminase ADAR1 by type I interferon differs between mouse and human cells in the requirement for STAT1.
George CX; Samuel CE
Virology; 2015 Nov; 485():363-70. PubMed ID: 26335850
[TBL] [Abstract][Full Text] [Related]
80. Escherichia coli infection activates the production of IFN-α and IFN-β via the JAK1/STAT1/2 signaling pathway in lung cells.
Jin Y; Jia Z; Cai Q; Sun Y; Liu Z
Amino Acids; 2021 Oct; 53(10):1609-1622. PubMed ID: 34524541
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
